← Human Trials & Peer-Reviewed Studies

Impact of a nutritional supplement during gestation and early childhood on child salivary cortisol, hair cortisol, and telomere length at 4-6 years of age: a follow-up of a randomized controlled trial.

Plain-language guide to PMID 32063089 (2020): randomized controlled trial of Copper (Supplement) in 364 children.

Key Facts

PMID
32063089
Journal
Stress (Amsterdam, Netherlands)
Year
2020
Study type
Randomized Controlled Trial
Authors
Oaks BM et al. (12 authors)
DOI
10.1080/10253890.2020.1728528
Registered trial
NCT00970866

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Copper (Supplement), published as a randomized controlled trial.

Their objective was to evaluate the long-term effect of nutritional supplementation during gestation and early childhood on child cortisol and buccal telomere length (a marker of cellular aging) at 4-6 years of age.

Why It Was Studied

Dysregulation of the stress response can occur early in life and may be affected by nutrition.

The researchers conducted a follow-up study of children born to women who participated in a nutritional supplementation trial in Ghana.

Who Took Part

The abstract describes 364 children taking part.

The age groups tagged for this paper are infants, young children, children and teenagers, women only.

How the Study Was Run

The researchers set it up as a randomized study.

Random assignment meant chance, not the researchers, decided who got Copper (Supplement) and who got the comparison, which limits bias.

What Was Measured

At age 4-6 years, the researchers measured hair cortisol, buccal telomere length, and salivary cortisol before and after a stressor.

Topics PubMed links to this paper include Dietary Supplements, Ghana, Hydrocortisone, Micronutrients, Stress, Psychological and Telomere.

Author keywords: Cortisol, child, nutrition, pregnancy and telomere length.

What This Means in Plain Language

The paper is a randomized study of Copper (Supplement) in 364 children.

With several hundred people or more, it is a fairly large study for this kind of research.

The publication is from 2020 (Stress (Amsterdam, Netherlands)), a journal based in England.

More context: the Copper (Supplement) compound page, all human trials.

Our Notes on the Compound

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.